| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |